- The seasonal influenza activity in the United States remains lower than usual for this time of year.
- In clinical laboratories, around 0.1% of respiratory specimens tested positive for influenza during the reported period.
- The number of influenza-positive specimens reported by public health labs remains unusually low.
- Outpatient visits for influenza-like illness (ILI) accounted for 0.9% of patient visits, which is below the national baseline of 2.6%.
- All jurisdictions experienced minimal ILI activity, but caution should be exercised in interpreting ILI activity levels due to the impact of the COVID-19 pandemic.
- The rate of hospitalizations for influenza-related illnesses is much lower than average for this point in the season.
- 11.4% of deaths were attributed to pneumonia, influenza, or COVID-19 (PIC), which is above the epidemic threshold.
- No influenza-associated pediatric deaths were reported during the reported period.
- CDC recommends annual flu vaccination and the use of antiviral drugs to treat flu illness.
- Additional surveillance information on influenza activity is available through national and international agencies and organizations.